1、raising standards worldwideNO COPYING WITHOUT BSI PERMISSION EXCEPT AS PERMITTED BY COPYRIGHT LAWBSI Standards PublicationBS EN ISO 18113-4:2011In vitro diagnostic medical devices Information supplied by the manufacturer (labelling)Part 4: In vitro diagnostic reagents for self-testing (ISO 18113-4:2
2、009)Incorporating corrigendum December 2011BS EN ISO 18113-4:2011 BRITISH STANDARDNational forewordThis British Standard is the UK implementation of EN ISO 18113-4:2011. It is identical to ISO 18113-4:2009. It supersedes BS EN ISO 18113-4:2009, which is withdrawn.The UK participation in its preparat
3、ion was entrusted to Tech-nical Committee CH/212, IVDs.A list of organizations represented on this committee can be obtained on request to its secretary.This publication does not purport to include all the necessary provi-sions of a contract. Users are responsible for its correct application. The Br
4、itish Standards Institution 2012 ISBN 978 0 580 77329 7ICS 11.100.10 Compliance with a British Standard cannot confer immunity from legal obligations.This British Standard was published under the authority of the Stan-dards Policy and Strategy Committee on 30 November 2011.Amendments/corrigenda issu
5、ed since publicationDate Text affected31 January 2012 Implementation of CEN correction notice 9November 2011: Corrected date of withdrawal in EN forewordEUROPEAN STANDARD NORME EUROPENNE EUROPISCHE NORM EN ISO 18113-4 October 2011 ICS 11.100.10 Supersedes EN ISO 18113-4:2009English Version In vitro
6、diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 4: In vitro diagnostic reagents for self-testing (ISO 18113-4:2009) Dispositifs mdicaux de diagnostic in vitro - Informations fournies par le fabricant (tiquetage) - Partie 4: Ractifs de diagnostic in vitro pour
7、 auto-tests (ISO 18113-4:2009) In-vitro-Diagnostika - Bereitstellung von Informationen durch den Hersteller - Teil 4: Reagenzien fr in-vitro-diagnostische Untersuchungen zur Eigenanwendung (ISO 18113-4:2009) This European Standard was approved by CEN on 20 September 2011. CEN members are bound to co
8、mply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this European Standard the status of a national standard without any alteration. Up-to-date lists and bibliographical references concerning such national standards may be obtained on application to the CEN-CENEL
9、EC Management Centre or to any CEN member. This European Standard exists in three official versions (English, French, German). A version in any other language made by translation under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management Centre has the
10、same status as the official versions. CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland,
11、 Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and United Kingdom. EUROPEAN COMMITTEE FOR STANDARDIZATION COMIT EUROPEN DE NORMALISATION EUROPISCHES KOMITEE FR NORMUNG Management Centre: Avenue Marnix 17, B-1000 Brussels 2011 CEN All rights of exploitation in any form and by any
12、means reserved worldwide for CEN national Members. Ref. No. EN ISO 18113-4:2011: EThe CEN correction notice 9 November 2011 provided a revised English language text, incorpotating the following editorial corrections:Changed date of withdrawal in the second paragraph of the Foreword.3 Forewo rd This
13、document (EN ISO 18113-4:2011) has been prepared by Technical Committee ISO/TC 212 “Clinicallaboratory testing and in vitro diagnostic test sy stems“ in collaboration with Technical Committee CEN/TC 140“In vitro diagnostic medical devices” the secretariat of which is held by DIN. This European Stand
14、ard shall be given the status of a national standard, either by publication of an identicaltext or by endorsement, at the latest by April 2012, and conflicting national standards shall be withdrawn at thelatest by October 2014. Attention is drawn to the possibility that some of the elements of this
15、document may be the subject of patentrights. CEN and/or CENELEC shall not be held responsible for identify ing any or all such patent rights. This document supersedes EN ISO 18113-4:2009. This new edition contains a revised Annex ZA. This document has been prepared under a mandate given to CEN by th
16、e European Commission and theEuropean Free Trade Association, and supports essential requirements of EU Directive. For relationship with EU Directive, see informative Annex ZA, which is an integral part of this document. According to the CEN/CENELEC Internal Regulations, the national standards organ
17、izations of the followingcountries are bound to implement this European Standard: Austria, Belgium, Bulgaria, Croatia, Cy prus, CzechRepublic, Denmark, Estonia, Finland, France, Germany , Greece, Hungary , Iceland, Ireland, Italy , Latvia,Lithuania, Luxembourg, Malta, Netherlands, Norway , Poland, P
18、ortugal, Romania, Slovakia, Slovenia, Spain,Sweden, Switzerland and United Kingdom. Endorsement notice The text of ISO 18113-4:2009 has been approved by CEN as EN ISO 18113-4:2011 without any modification. BS EN ISO 18113-4:2011 EN ISO 18113-4:2011 (E)4 BS EN ISO 18113-4:2011 EN ISO 18113-4:2011 (E)
19、Annex ZA (informative) Relationship between this European Standard and the Essential Requirements of the EU Directive 98/79/EC on “in vitro Diagnostic Medical Devices” This European Standard has been prepared under a mandate given to CEN by the European Commission to provide a means of conforming to
20、 the Essential Requirements of the New Approach Directive 98/79/EC on “in vitro Diagnostic Medical Devices”. Once this European Standard is cited in the Official Journal of the European Union under that Directive and has been implemented as national standard in at least one Member State, compliance
21、with the clauses of this standard given in Table ZA.1 confers, within the limits of the scope of this European Standard, a presumption of conformity with the corresponding Essential Requirements of that Directive and associated EFTA regulations. Table ZA.1 Correspondence between this European Standa
22、rd and European Directive 98/79/EC Clauses of this European Standard Essential Requirements (ERs) of Directive 98/79/EC Qualifying comments/Notes 4.3, 6.1, 7.3, 7.11 B.7 These clauses only cover the second sentence of ER B.7, namely the labelling requirements. 4.2, 4.3, 5, 6, 7 B.8.1 Presumption of
23、conformity with ER B.8.1 also requires compliance with clauses 4.1, 4.2.1 and 4.6 of EN ISO 18113-1. 5.8, 6.8, 7.9 B.8.3 NOTE 2 5.1, 6.2 B.8.4(a) NOTE 1 5.2, 5.3, 6.3.1, 6.4 B.8.4(b) 5.2.2, 6.3.2 B.8.4(d) Full compliance to ER B.8.4(d) requires the use of EN 980, clause 5.4, symbol (LOT). 5.7, 6.7 B
24、.8.4(e) 5.5, 6.5 B.8.4(g) 5.6, 6.6 B.8.4(h) 5.8, 6.8 B.8.4(j) NOTE 2 5.4 B.8.4(k)5.4, 7.3 B.8.5 5.2.2, 6.3.2 B.8.6 7.1, 7.2, 7.3, 7.8, 7.9 B.8.7(a) Presumption of conformity with ER B. 8.7(a) requires also compliance with clause 4.5 of EN ISO 18113-1. NOTE 1, NOTE 3 7.5 B.8.7(b) 7.8 B.8.7(c) 7.6 B.8
25、.7(e) 7.10 B.8.7(f) 7.11 B.8.7(g) 5 BS EN ISO 18113-4:2011 EN ISO 18113-4:2011 (E)Clauses of this European Standard Essential Requirements (ERs) of Directive 98/79/EC Qualifying comments/Notes 7.4, 7.7 B.8.7(h) 7.12 B.8.7(k)NOTE 3 7.6 B.8.7(m) 7.9 B.8.7(s)7.13, 7.14, 7.15, 7.16, 7.17 B.8.7(t) NOTE 1
26、 In the European Union, the name and address of the manufacturers “EC Authorized representative” is required on the outer container label or in the instructions for use, if the legal manufacturer is not located within the European Union. NOTE 2 Essential Requirement B.8.3 of Directive 98/79/EC shoul
27、d be consulted for a comprehensive list of the information required. NOTE 3 Essential Requirement B.8.7 of Directive 98/79/EC should be consulted for a comprehensive list of the information required. iiiContents Page Foreword iv Introduction.v 1 Scope1 2 Normative references1 3 Terms and definitions
28、 .1 4 General .2 4.1 Essential requirements.2 4.2 Identification of kit components 2 4.3 Presentation of the instructions for use .2 5 Content of the outer container label2 5.1 Manufacturer2 5.2 Identification of the IVD reagent 2 5.3 Contents .3 5.4 Intended use 3 5.5 In vitro diagnostic use 3 5.6
29、Storage and handling conditions 3 5.7 Expiry date .3 5.8 Warnings and precautions .4 6 Content of the immediate container label.4 6.1 General provisions 4 6.2 Manufacturer4 6.3 Identification of the IVD reagent 4 6.4 Contents .4 6.5 In vitro diagnostic use 4 6.6 Storage and handling conditions 5 6.7
30、 Expiry date .5 6.8 Warnings and precautions .5 7 Content of the instructions for use .5 7.1 Manufacturer5 7.2 Identification of the IVD reagent 5 7.3 Intended use 5 7.4 Principles of the examination method 6 7.5 Components.6 7.6 Additional required equipment 6 7.7 Reagent preparation6 7.8 Storage a
31、nd shelf life after first opening 6 7.9 Warnings and precautions .6 7.10 Primary sample collection, handling and storage .7 7.11 Examination procedure.7 7.12 Control procedure .7 7.13 Reading of examination results .7 7.14 Interpretation of results 7 7.15 Performance characteristics 7 7.16 Biologica
32、l reference intervals 8 7.17 Limitations of examination procedure 8 7.18 Literature references.8 Bibliography9 BS EN ISO 18113-4:2011 EN ISO 18113-4:2011 (E) ISO 2011 iv Foreword ISO (the International Organization for Standardization) is a worldwide federation of national standards bodies (ISO memb
33、er bodies). The work of preparing International Standards is normally carried out through ISO technical committees. Each member body interested in a subject for which a technical committee has been established has the right to be represented on that committee. International organizations, government
34、al and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization. International Standards are drafted in accordance with the rules given in the ISO/IEC Direct
35、ives, Part 2. The main task of technical committees is to prepare International Standards. Draft International Standards adopted by the technical committees are circulated to the member bodies for voting. Publication as an International Standard requires approval by at least 75 % of the member bodie
36、s casting a vote. Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. ISO shall not be held responsible for identifying any or all such patent rights. ISO 18113-4 was prepared by Technical Committee ISO/TC 212, Clinical laboratory tes
37、ting and in vitro diagnostic test systems ISO 18113 consists of the following parts, under the general title In vitro diagnostic medical devices Information supplied by the manufacturer (labelling): Part 1: Terms, definitions and general requirements Part 2: In vitro diagnostic reagents for professi
38、onal use Part 3: In vitro diagnostic instruments for professional use Part 4: In vitro diagnostic reagents for self-testing Part 5: In vitro diagnostic instruments for self-testing BS EN ISO 18113-4:2011 EN ISO 18113-4:2011 (E) ISO 2011 vIntroduction Manufacturers of in vitro diagnostic (IVD) reagen
39、ts for self-testing supply users with information to enable the safe use and expected performance of their devices. The type and level of detail varies according to the intended uses and country-specific regulations. The Global Harmonization Task Force (GHTF) encourages convergence of the evolution
40、of regulatory systems for medical devices at the global level. Eliminating differences among regulatory jurisdictions could allow patients earlier access to new technologies and treatments. See Reference 9. This part of ISO 18113 provides a basis for harmonization of labelling requirements for IVD r
41、eagents for self-testing. This part of ISO 18113 is concerned solely with information supplied with IVD reagents, calibrators and control materials intended for self-testing. It is intended to be used in conjunction with ISO 18113-1, which contains the general requirements for information supplied b
42、y the manufacturer and definitions of general labelling concepts. This part of ISO 18113 is based on EN 376:20025. The text has been modified to conform to Part 2 of the ISO/IEC Directives4, but the requirements, including those in ISO 18113-1, are substantially equivalent to the original European h
43、armonized standard. This part of ISO 18113 is intended to support the essential labelling requirements of all the GHTF partners, as well as other countries that have enacted or plan to enact labelling regulations for IVD medical devices. For IVD reagents, calibrators and/or control materials that ar
44、e intended to be used as a system with an instrument provided by the same manufacturer, this part of ISO 18113 is also intended to be used together with ISO 18113-1 and ISO 18113-53. BS EN ISO 18113-4:2011 EN ISO 18113-4:2011 (E) ISO 2011 INTERNATIONAL STANDARD1In vitro diagnostic medical devices In
45、formation supplied by the manufacturer (labelling) Part 4: In vitro diagnostic reagents for self-testing 1 Scope This part of ISO 18113 specifies requirements for information supplied by the manufacturer of IVD reagents for self-testing. This part of ISO 18113 also applies to information supplied by
46、 the manufacturer with calibrators and control materials intended for use with IVD medical devices for self-testing. This part of ISO 18113 can also be applied to accessories. This part of ISO 18113 applies to the labels for outer and immediate containers and to the instructions for use. This part o
47、f ISO 18113 does not apply to: a) IVD instruments or equipment, b) IVD reagents for professional use. 2 Normative references The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the la
48、test edition of the referenced document (including any amendments) applies. ISO 14971, Medical devices Application of risk management to medical devices ISO 15223-1, Medical devices Symbols to be used with medical device labels, labelling and information to be supplied Part 1: General requirements ISO 18113-1, In vitro diagnostic medical devices Information supplied by the manufacturer (labelling) Part 1: Terms, definitions and general requirements EN 980, Symbols for use in the labelling of medical devices 3 Terms and definitions For the purposes of this document, the
